Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Human Autologous Mesenchymal Stromal Cells for the Treatment of Mid to Late Stage Knee Osteoarthritis

NCT02351011 is registered in ClinicalTrials.gov with Jas Chahal as lead sponsor.

NCT NCT02351011
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02351011 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Human Autologous Mesenchymal Stromal Cells for the Treatment of Mid to Late Stage Knee Osteoarthritis
Lead sponsor
Jas Chahal
Phase
Phase 1/2
Overall status
Completed
Start date
February 28, 2015
Completion date
December 31, 2018
Enrollment
12 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

osteoarthritis of knee